(1147–1190) Miscellaneous Rheumatic & Inflammatory Diseases Poster II

Monday, October 27, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

A Comparison of Patients with Cardiac Sarcoidosis vs. Other Systemic Manifestations of Sarcoidosis: A Retrospective Cohort Study
Abstract Poster Presenter: Chelsea Guan, MD – University Hospitals Cleveland Medical Center/Case Western Reserve University
10:30 AM - 12:30 PM Central Time

A Phase II, Single-site, Open-label Study of Zanubrutinib in Patients with igg4-related Disease
Abstract Poster Presenter: Matthew Baker, MD, MS – Stanford University
10:30 AM - 12:30 PM Central Time

A20 Haploinsufficiency (HA20): TNFAIP3 Mutation Prevalence in a Clinically Compatible Cohort
Abstract Poster Presenter: María Alonso de Francisco, MD – H. U. San Pedro
10:30 AM - 12:30 PM Central Time

An International Modified Delphi Study on the Evolving Role of Janus Kinase Inhibitors (JAKi) in Rheumatic and Musculoskeletal Diseases (RMDs)
Abstract Poster Presenter: Philip J. Mease, MD – Swedish Medical Center/Providence St. Joseph Health
10:30 AM - 12:30 PM Central Time

Antineutrophil Cytoplasmic Antibody-associated Isolated Interstitial Lung Disease
Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
10:30 AM - 12:30 PM Central Time

Aortic Wall Shear Stress May Be a Protective Factor Against Development of Spinal Osteoproliferation
Abstract Poster Presenter: Umut Kalyoncu, n/a – Division of Rheumatology, Department of Internal Medicine, Hacettepe University School of Medicine, Ankara, Turkey
10:30 AM - 12:30 PM Central Time

Assessment of Damage Using the igg4-related Disease Damage Index
Abstract Poster Presenter: Eduardo Martin-Nares, MD, MSc – Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
10:30 AM - 12:30 PM Central Time

Biomarkers Associated with Left Atrial Structure and Function in Individuals with Psoriasis
Abstract Poster Presenter: Julie Borchsenius, MD (she/her/hers) – CTCPR / Center for translational cardiology and pragmatic research trials
10:30 AM - 12:30 PM Central Time

Cardiac Sarcoidosis in Black Patients: A Biopsy-Confirmed Cohort Study
Abstract Poster Presenter: Roshan Subedi, MD – Georgetown/Washington Hospital Center
10:30 AM - 12:30 PM Central Time

Clinical and Biomarker Characteristics of Inebilizumab-Treated Participants Who Experienced an IgG4-RD Flare During the Phase 3 MITIGATE Trial
Abstract Poster Presenter: John Stone, MD, MPH – Massachusetts General Hospital , Harvard Medical School
10:30 AM - 12:30 PM Central Time

Clinical and Genetic Features of CTLA-4 Haploinsufficiency : A Prospective Study in China
Abstract Poster Presenter: guishan liu, PA – Peking Union Medical College Hospital
10:30 AM - 12:30 PM Central Time

Clinical Characteristics and Outcomes of igg4-related Disease Patients Who Chose Watchful Observation Without Treatment Intervention: A Single-center Study
Abstract Poster Presenter: Kanako Chujo, MD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
10:30 AM - 12:30 PM Central Time

Clinical Outcomes and Response to SARS-Cov-2 Infection and Vaccination in Ianalumab‑Treated Patients with Autoimmune Diseases
Abstract Poster Presenter: Valerie Devauchelle, MD;PhD (she/her/hers) – UBO
10:30 AM - 12:30 PM Central Time

Clinical Relevance of Tumor Necrosis Factor Superfamily Cytokines
Abstract Poster Presenter: Robert Corty, MD, PhD (he/him/his) – Vanderbilt University Medical Center
10:30 AM - 12:30 PM Central Time

Comparative efficacy, safety and tolerability of antifibrotic therapies across systemic autoimmune diseases
Abstract Poster Presenter: Javier Narvaez, PhD – Hospital Universitario de Bellvitge
10:30 AM - 12:30 PM Central Time

Cutaneous Panniculitis in Rheumatology: A Descriptive Cohort Study from a Multidisciplinary Experience
Abstract Poster Presenter: Claudia Campos-Fabre, MD, MEd – Hospital Universitario La Paz
10:30 AM - 12:30 PM Central Time

Does Blocking IL-17 Treat Recalcitrant Uveitis? Explorative Study on the Use of Ixekizumab to Manage Patients with Uveitis.
Abstract Poster Presenter: Sergio Schwartzman, MD – Weill Cornell Medical Center, New York Presbyterian Hospital, and Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Effect of TNF Inhibitors on the Postprandial Glucose Homeostasis Molecules: Amylin, Gastric Inhibitory Polypeptide, and Pancreatic Polypeptide in Rheumatic Patients
Abstract Poster Presenter: José Carlos García-Hernández, n/a (he/him/his) – Hospital Universitario de Canarias
10:30 AM - 12:30 PM Central Time

Efficacy and Safety of Ruxolitinib in Adult Patients With Refractory Connective Tissue Disease-Associated Macrophage Activation Syndrome
Abstract Poster Presenter: Qiong Fu, MD (she/her/hers) – Renji Hospital
10:30 AM - 12:30 PM Central Time

Gender-Based Clinical Differences in Behçet’s Syndrome: Findings from a 24-Year Cohort in a Non-Endemic and Multiethnic Country
Abstract Poster Presenter: Rafael Bassara Macedo, MD – Rheumatology Division - University of São Paulo
10:30 AM - 12:30 PM Central Time

High Prevalence of Autoimmunity in Rosai Dorfman Disease: A Multinational Study
Abstract Poster Presenter: Mitali Sen, MD (she/her/hers) – University of Alabama at Birmingham
10:30 AM - 12:30 PM Central Time

IgG4-related disease with comorbid autoimmune diseases: a retrospective study from a large cohort
Abstract Poster Presenter: Xinli Yang, MD – Peking Union Medical College
10:30 AM - 12:30 PM Central Time

IL-18 Correlates with Pouchot Score and Inflammatory Biomarkers in Adult-Onset Still’s Disease: Insights From a Repeated Measures Study
Abstract Poster Presenter: Hadeel Abdul-Rehman, BS – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Impact of IL-17A on synovial fibroblast from subacromial bursae
Abstract Poster Presenter: Andre Ramon, MD, PhD – Dijon University Hospital
10:30 AM - 12:30 PM Central Time

Incidence and Prevalence of Interstitial Pneumonia with Autoimmune Features in a Population-Based Cohort
Abstract Poster Presenter: Elena Joerns, MD, MPH – Mayo Clinic
10:30 AM - 12:30 PM Central Time

Increased Adoption of IL-1 Pathway Inhibition and the Steroid-sparing Paradigm Shift: Temporal Trends in Recurrent Pericarditis Treatment From the RESONANCE Patient Registry
Abstract Poster Presenter: Sue Gibbons, MSN – Kiniksa
10:30 AM - 12:30 PM Central Time

Interstitial Lung Disease in MCTD: A Retrospective Cohort Study at a Large Tertiary Medical Center
Abstract Poster Presenter: Alana Haussmann, MD (she/her/hers) – University of California Los Angeles
10:30 AM - 12:30 PM Central Time

Interstitial Lung Disease-Associated Antibody Testing and Positivity Rates in Systemic Autoimmune Rheumatic Diseases from a National Reference Laboratory
Abstract Poster Presenter: Karis Lee, APRN – Labcorp
10:30 AM - 12:30 PM Central Time

Myositis-Specific Antibody Profiles and Factors Associated With Rapidly Progressive Interstitial Lung Disease and Mortality in Antisynthetase Syndrome: A Systematic Review and Meta-Analysis
Abstract Poster Presenter: Tulaton Sodsri, MD – Texas Tech University Health Sciences Center
10:30 AM - 12:30 PM Central Time

New Disease Classification in the Block? A 5-year Retrospective Review on Clinical Profiles and Mortality Outcomes of Patients Presenting with Hematoinflammatory Syndromes at a University Center in Florida
Abstract Poster Presenter: Cristine Arcilla, MD (she/her/hers) – Lakeland Regional Health
10:30 AM - 12:30 PM Central Time

Patient Symptom State Demonstrates Validity for the Assessment of Disease Activity and Patient-reported Outcomes in Adults with SAPHO and Chronic Nonbacterial Osteomyelitis – A Longitudinal Response Profile Analysis in The SAPHO-CNO Study
Abstract Poster Presenter: Aleksander Lenert, MD;MS;FRCPC – University of Iowa
10:30 AM - 12:30 PM Central Time

Periodontitis in neutropenic DADA2 patients
Abstract Poster Presenter: Lorena Wilson, PhD, CRNP – National Institutes of Health
10:30 AM - 12:30 PM Central Time

Plasma Adenosine Deaminase 2 as a Potential Disease Activity Biomarker for Sarcoidosis
Abstract Poster Presenter: Jamie Lim, BS (she/her/hers) – Duke University School of Medicine
10:30 AM - 12:30 PM Central Time

Pregnancy Outcomes in Women with Familial Mediterranean Fever Treated with Anakinra: A Retrospective Study
Abstract Poster Presenter: Ozgur Can Kilinc, n/a – Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa
10:30 AM - 12:30 PM Central Time

Prevalence of Coronary Artery Involvement in IgG4-Related Disease Detected by Non-Gated Cross-Sectional Imaging
Abstract Poster Presenter: Matthew Baker, MD, MS – Stanford University
10:30 AM - 12:30 PM Central Time

Pulmonary Arterial Hypertension in Adults with Still’s Disease: Another Pulmonary Manifestation Associated with HLA-DRB1*15
Abstract Poster Presenter: STEPHANE MITROVIC, MD, MSc – Pitié-Salpêtrière Hospital, Rheumatology Department, APHP, Sorbonne University,
10:30 AM - 12:30 PM Central Time

Real-World On-Label Treatment Persistence Through 24 Months in Biologic-Naïve and Biologic-Experienced Patients with Psoriatic Arthritis: Comparison of Guselkumab versus Subcutaneous Tumor Necrosis Factor Inhibitors
Abstract Poster Presenter: Joseph Merola, MD, MSc, FACR, FAAD – UT Southwestern Medical Center
10:30 AM - 12:30 PM Central Time

Renal Manifestations in VEXAS Syndrome: A Systematic Review of Clinical Features, Pathology, and Outcomes
Abstract Poster Presenter: Akhila Arya P V, MD (she/her/hers) – Yale University/Bridgeport Hospital
10:30 AM - 12:30 PM Central Time

Risk of Inflammatory Bowel Disease in Psoriatic Arthritis Patients Treated with IL-17 Inhibitors
Abstract Poster Presenter: Rusudan Tskitishvili, MD – Virtua Health
10:30 AM - 12:30 PM Central Time

Safety and Tolerability of a Recombinant Zoster Vaccine in Patients with Inflammatory Rheumatic Musculoskeletal Diseases: A Prospective Longitudinal Study over 12 Months
Abstract Poster Presenter: Ella Steiner, -None- – Ruhr-University Bochum, Germany
10:30 AM - 12:30 PM Central Time

Secukinumab In Patients with Giant Cell Arteritis with Polymyalgia Rheumatica Symptoms: A Post Hoc Analysis of the Phase 2 TitAIN Study
Abstract Poster Presenter: Nils Venhoff, MD – Department of Rheumatology and Clinical Immunology, Medical Center, Faculty of Medicine, University of Freiburg
10:30 AM - 12:30 PM Central Time

VEXAS Syndrome Under the Lens: A prospective analysis of temporal disease patterns, biomarker Dynamics, and therapeutic efficacy
Abstract Poster Presenter: Marta López, MD – Complex Hospitalari Universitari Moisès Broggi
10:30 AM - 12:30 PM Central Time

VISIBLE Post-Inflammatory Pigmentation Journeys: Exploring the Impact of Pigmentation
Abstract Poster Presenter: Oyediran Adelakun, MPH – Janssen Research & Development, LLC
10:30 AM - 12:30 PM Central Time

Zasocitinib (TAK-279), an Investigational, Oral, Allosteric, Selective TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: Efficacy Analysis by Baseline Characteristics from a Randomized Phase 2b Trial
Abstract Poster Presenter: Ejim Mark, MD, MPH, MBA – Self Employed